drugset / Trial / NCT00919243

Prednisone for Heart Failure Patients With Hyperuricemia

NCT00919243

Phase 4 Completed 40 enrolled Hebei Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

Hyperuricemia is a very common finding in patients with heart failure. It is usually related to diuretic use and deteriorated renal function. The recently evidence showed that uric acid (UA) lowering therapy may improve clinical status in symptomatic heart failure patients with hyperuricemia. In their clinical practice, the investigators found that glucocorticoids could dramatically lower UA while improving renal function. Thus the investigators design this randomized head to head study to test our hypothesis that prednisone have the same efficacy to allopurinol on lowering UA and could improve renal function at the same time.

Timeline

Start
2009-02
Primary completion
2010-07
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Allopurinol Small molecule 100 mg Oral
Subject Prednisone Other / unclassified 1 mg/kg Oral

Indications